- Home
- TNGX vs EQBK Comparison
TNGX vs EQBK Comparison
Compare TNGX & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- EQBK
- Stock Information
- Founded
- TNGX 2014
- EQBK 2002
- Country
- TNGX United States
- EQBK United States
- Employees
- TNGX N/A
- EQBK N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- EQBK Major Banks
- Sector
- TNGX Health Care
- EQBK Finance
- Exchange
- TNGX Nasdaq
- EQBK Nasdaq
- Market Cap
- TNGX 413.6M
- EQBK 750.4M
- IPO Year
- TNGX N/A
- EQBK 2015
- Fundamental
- Price
- TNGX $3.13
- EQBK $41.35
- Analyst Decision
- TNGX Strong Buy
- EQBK Hold
- Analyst Count
- TNGX 8
- EQBK 4
- Target Price
- TNGX $13.14
- EQBK $44.50
- AVG Volume (30 Days)
- TNGX 1.4M
- EQBK 74.5K
- Earning Date
- TNGX 11-06-2024
- EQBK 01-22-2025
- Dividend Yield
- TNGX N/A
- EQBK 1.29%
- EPS Growth
- TNGX N/A
- EQBK N/A
- EPS
- TNGX N/A
- EQBK 1.12
- Revenue
- TNGX $43,383,000.00
- EQBK $157,755,000.00
- Revenue This Year
- TNGX $27.73
- EQBK N/A
- Revenue Next Year
- TNGX N/A
- EQBK $6.05
- P/E Ratio
- TNGX N/A
- EQBK $37.40
- Revenue Growth
- TNGX 15.67
- EQBK N/A
- 52 Week Low
- TNGX $2.70
- EQBK $30.44
- 52 Week High
- TNGX $13.01
- EQBK $50.85
- Technical
- Relative Strength Index (RSI)
- TNGX 42.05
- EQBK 26.55
- Support Level
- TNGX $2.95
- EQBK $40.84
- Resistance Level
- TNGX $3.20
- EQBK $43.14
- Average True Range (ATR)
- TNGX 0.27
- EQBK 1.44
- MACD
- TNGX 0.08
- EQBK -0.39
- Stochastic Oscillator
- TNGX 72.88
- EQBK 7.76
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.